Korro Bio, INC Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
NASDAQ
KRRO
Korro Bio, INCKorro Bio, Inc. has filed an amendment to its Schedule 13D, detailing significant transactions in its common stock by major holders Atlas XI and AVOF II over the past sixty days.
NASDAQ
KRRO
Korro Bio, INCNew Enterprise Associates 17, L.P. and its affiliates increased their beneficial ownership in Korro Bio, Inc. to 9.9% through a recent private placement.